retatrutide clinical trials safety efficacy New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide FDA Approval Status 2026:

You have metabolic dysfunction-associated steatohepatitis (a type of fatty liver disease) or obstructive sleep apnea

Theyre still classified as diabetes and weight-loss medications, so doctors dont prescribe them off-label for substance use disorders

Shipping One-day shipping included at no additional cost

It Wont Build Muscle GLP-1s can help reduce cravings and support weight loss but they cant build strength

More Psychedelic Passage Listen to our podcast on Spotify or Apple Podcasts Subscribe to our YouTube Channel Frequently Asked Questions 1

GLPura nest pas destin aux personnes de moins de 18 ans, ni celles qui sont enceintes ou allaitantes sans avis mdical